Pinned Tweet
BASIL-2 results revealed! Thank you to everyone's hard work and efforts on the BASIL-2 trial.
The BASIL-2 results have been revealed at #CX2023.
A best endovascular treatment first revascularisation strategy was associated with a better amputation-free survival over the vein bypass group for patients with CLTI.
Watch LIVE now: bit.ly/3mZlHEU
BASIL-2 has been selected by NIHR to be included as an NIHR alert. Read the summary on NIHR Evidence here evidence.nihr.ac.uk/alert/ar…
BASIL Trials retweeted
Tomorrow is International Clinical Trials Day! We thank all who take part in clinical trials in the Yorkshire and Humber region.
Research is for everyone and your participation helps us make patients, and health and social care better.
#ICTD2023 #BePartOfResearch #NHS75
Lisa Kelly, BASIL Research Nurse at Solihull Research Showcase – celebrating BASIL trials for International Trials Day! #bepartofresearch
BASIL Trials retweeted
Charing Cross' new community platform - CX Vascular is now LIVE! #CXVascular is FREE to join and as a member of our community, you'll have access to a range of features and resources, as well as exclusive educational content.
⚡ EXCLUSIVE EDUCATIONAL CONTENT AVAILABLE NOW ⚡
BASIL Trials retweeted
Today #BCTU is celebrating 25 years! For the past 25 years BCTU has provided scientific and technical expertise to facilitate the delivery of clinical trials from conception to completion. Cheers to another 25!
BASIL Trials retweeted
#CTD2021 This year has showcased the power of science, research and clinical trials
BASIL Trials retweeted
#BCTU #AdventCalendar 3rd December: did you know all CTIMP applications should be submitted via CWOW from 1st January 20222 #hra #clinicaltrials
#Thankyou to all the amazing and hard working researchers who are working on BASIL-3. We have now completed recruitment and will be excited to keep you updated with the developments.
7 participants to achieve recruitment! Thank you
@a_saratzis
@LeicResearch
@WythenshaweHosp
@HullHospitals
@GSTTnhs
@EndovascularU
@ChetterIan
#CTD2021 This year has highlighted the true power of science and clinical trials #BASIL3 will answer the important #paclitaxel question! 13 patients to complete recruitment!
#BASIL3 is still recruiting! 20 patients to achieve target. Thank you to @a_saratzis @LeicResearch for recruiting the first patients of 2021.
BASIL-3 is still recruiting! 25 patients to achieve target. Thank you very much to all the sites who are working hard on this trial @WythenshaweHosp @GSTTnhs @LeicResearch @HullHospitals @LTHTResearch @SheffieldHosp @DCHFT @SouthmeadHospit
BASIL Trials retweeted
BASIL-2 Study ID: 27728689
BASIL-3 Study ID: 14469736
Site ID's:
RXK - (Sandwell)
RKB - University Hospital Coventry & Warwickshire
RRK - Queen Elizabeth Hospital
RWP - Worcestershire Royal Hospital
RNA - Dudley Group
RL4 - Royal Wolverhampton
RJE - UHNM
If you are a West Midlands site that has recruited to BASIL2/3, please could you take a few minutes to complete the PRES 2020/21, the link can be found here: forms.gle/dKE29jX4dEJDy9mL7
You will be required to enter the study ID and your site ID which can be found below...
BASIL Trials retweeted
Replying to @jmills1955 @VascularSVS @BCM_Surgery @diabeticfoot1 @robhinchliffe1 @EJVES_ESVS @VASCevidence @basil_trials @dgarmstrong
Absolutely.. the 2 minute toe pressure challenge is a ‘fun’ awareness raising initiative to help bust the myth that toe pressures are complicated & time consuming. We need lots more front line lower limb clinicians becoming #WIfI ready. Have proper cabability tool as follow-up👍
BASIL Trials retweeted
Measure carefully before you cut #ComprehensiveVascularCare #WIfI #DFU #LimbSalvage @VascularSVS @BCM_Surgery @diabeticfoot1 @robhinchliffe1 @EJVES_ESVS @VASCevidence @basil_trials @diabeticfoot1 @dgarmstrong
Replying to @suematpad @mcrlco
Technically, it was the 2 minute thumb pressure challenge today, so my time doesn’t count as a new world record 😂 Loads of Manchester’s lower limb clinicians had a go and nailed it in 1-2 mins 🙌 Piqued interest. 1st step to a more #WIfI ready workforce #savinglivesandlimbs
Amazing team @WythenshaweHosp for #recruiting 13 pts to #basil 3 since Sep 2019!!! @NIHRresearch @VSGBI @BSIR_News @NIHRevidence
BASIL-3 will answer this - thank you everyone supporting to the trial!:
Paclitaxel mortality signal inconsistent across different geographies vascularnews.com/paclitaxel-…
















